Defended May 28, Defended August 27, Intrinsic radiation resistance of mesenchymal cancer stem cells and implications for treatment response in a murine sarcoma model. Defended June 15 Defended October 18, Dynamic multileaf collimator tracking and dose delivery for moving targets in radiotherapy. Defended February 24,
Defended August 20, Defended December 9, Defended December 13, Defended March 6, Impact of age and intrinsic subtype on the long-term failure pattern in low-risk breast cancer. Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy. Defended June 4,
Long-term follow-up after modern radical prostate cancer radiotherapy – exploring the use of MRI delineation and a NI-TI stent as fiducial marker. Defended June 24, Recurrence location after definitive chemo radiation therapy for head and neck squamos cell carcinoma in relation to clinical target volumes and 18F -FDG uptake.
Defended August 18, Defended September 11, Dynamic multileaf collimator tracking and dose delivery for moving targets in radiotherapy.
Three-dimensional optical bases dosimetry: Evaluation and optimization of modern treatment planning and pnd techniques. Dose calculation based on Cone Beam CT images. Reduction of dysphagia-related morbidity in head and neck radiotherapy. Defended December 21, Image registration and image segmentation for image-guided radiotherapy of prostate cancer.
Defended October 30, Role of extensive surgery with or without interstitial brachytherapy in advanced primary or locally recurrent rectal cancer. Organ Motion — 4D imaging and treatment.
Monte Carlo based treatment plans for radiotherapy: Defended April 4, Radiation-induced hypothyroidism after treatment of head-and-neck cancer.
Improving Ion Computed Tomography. Defended November 23, Characterization of new breast cancer susceptibility genes with impact on prognosis and design of novel anticancer therapies. Defended August 21, Defended May 16, cmat Defended June 25, Clinical implementation and early outcome.
CIRRO – PhD and Master’s Theses
Defended August 29, Defended May 28, Project completed March Second primary cancers after adjuvant radiotherapy in early breast cancer patients. Importance of follow-up after treatment for head and neck cancer. Intervention thesi radiation-induced skin fibrosis by RNA interference. Risk of heart disease in modern breat cancer radiotherapy.
Morbidity in patients with prostate cancer treated with radiation therapy. Defended August 20, Intrinsic radiation resistance of mesenchymal cancer stem cells and implications for treatment response in a murine sarcoma model.